The metabolic disposition of 14C-ciramadol in humans.
Twelve subjects received single 15 mg oral doses of 14C-ciramadol. Excretion of the dose occurred almost entirely by the renal route (93.5 +/- 11.7 (S.D.)% of the dose), and only 0.7 +/- 0.6% of the dose was recovered in faeces indicating that absorption was essentially complete. More than 90% of the amount recovered in urine was excreted within 24 h after dosing. Unchanged drug accounted for 43.9 +/- 6.5% of the dose, while a phenolic glucuronide conjugate was the only major urinary metabolite accounting for a further 37.9 +/- 7.8%. A second glucuronide that was conjugated with the alicyclic ring was also identified but constituted only 2.3 +/- 0.6% of the dose. Concentrations of radioactivity in plasma reached a peak at 2 h after dosing and declined with a terminal disposition half life of 4.9 h. Only ciramadol and the aryl-O-glucuronide were detected in substantial amounts in plasma. Renal clearance of ciramadol amounted to 298 +/- 54 ml/min suggesting tubular secretion in addition to glomerular filtration.
D000328:Adult; D000588:Amines / Q000378:metabolism*; D000700:Analgesics / Q000378:metabolism* / Q000652:urine; D001596:Benzylamines / Q000378:metabolism* / Q000652:urine; D001711:Biotransformation; D005243:Feces / Q000032:analysis; D006801:Humans; D007700:Kinetics; D008297:Male
D000588:Amines; D000700:Analgesics; D001596:Benzylamines; C018273:ciramadol